Projects per year
Fingerprint
Dive into the research topics where Evanthia Galanis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Center of Innovation for Brain Tumor Therapeutics
Bindra, R., Galanis, E., Omuro, A. & Sarkaria, J. N.
9/1/21 → 8/31/22
Project: Research project
-
Novel multipronged Immunovirotherapy Approach for GBM Treatment
3/1/21 → 2/28/22
Project: Research project
-
Optimizing Delivery of Oncolytic Measles Virus Strains with Cell Carriers
3/2/17 → 2/29/20
Project: Research project
-
Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas
1/1/11 → 12/31/16
Project: Research project
-
Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer
6/1/09 → 12/31/14
Project: Research project
Research output
-
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
Jalalirad, M., Haddad, T. C., Salisbury, J. L., Radisky, D., Zhang, M., Schroeder, M., Tuma, A., Leof, E., Carter, J. M., Degnim, A. C., Boughey, J. C., Sarkaria, J., Yu, J., Wang, L., Liu, M. C., Zammataro, L., Malatino, L., Galanis, E., Ingle, J. N., Goetz, M. P. & 1 others, , Apr 8 2021, In: Oncogene. 40, 14, p. 2509-2523 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
CODEL: Phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Jaeckle, K. A., Ballman, K. V., Van Den Bent, M., Giannini, C., Galanis, E., Brown, P. D., Jenkins, R. B., Cairncross, J. G., Wick, W., Weller, M., Aldape, K. D., Dixon, J. G., Anderson, S. K., Cerhan, J. H., Wefel, J. S., Klein, M., Grossman, S. A., Schiff, D., Raizer, J. J., Dhermain, F. & 3 others, , Mar 1 2021, In: Neuro-oncology. 23, 3, p. 457-467 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer
Rocconi, R. P., Monk, B. J., Walter, A., Herzog, T. J., Galanis, E., Manning, L., Bognar, E., Wallraven, G., Stanbery, L., Aaron, P., Senzer, N., Coleman, R. L. & Nemunaitis, J., Jun 2021, In: Gynecologic oncology. 161, 3, p. 676-680 5 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy
Panagioti, E., Kurokawa, C., Viker, K., Ammayappan, A., Anderson, S. K., Sotiriou, S., Chatzopoulos, K., Ayasoufi, K., Johnson, A. J., Iankov, I. D. & Galanis, E., Jul 2021, In: Journal of Clinical Investigation. 131, 13, e141614.Research output: Contribution to journal › Article › peer-review
Open Access -
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma
Galanis, E., Wen, P. Y., de Groot, J. F. & Weller, M., Feb 2022, In: Hematology/Oncology Clinics of North America. 36, 1, p. 113-132 20 p.Research output: Contribution to journal › Review article › peer-review